Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,466.00    26.00 (1.81%)
Bid:
1,462.00
Ask:
1,470.00
Spread: 8.00 (0.547%)
Market Cap: £501.92m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Statement

11 Jan 2008 07:01

Craneware plc11 January 2008 Craneware plc ("Craneware" or the "Company") H1 TRADING UPDATE 11 January 2008 - Craneware plc, (AIM: CRW) a leader in revenue cyclemanagement software solutions for the US healthcare market, is pleased to givean update today on trading during the half year to 31 December 2007. Following the Company's IPO on AIM in September 2007, Craneware has executed onits strategy to further advance its market leading position. In the six monthsto 31 December 2007, the Company signed up 96 new hospitals, compared to 64 inthe previous corresponding period. As a result, the Company's software is nowbeing used in 878 hospitals in the US, up from 800 at the beginning of the year. Revenue for the first half of the year was in line with management expectations,with new sales bookings being over 50% higher than the previous correspondingperiod. Craneware's flagship product, Chargemaster Toolkit(R), was also onceagain named top in its class by the prestigious industry research house KLAS inthe US. As stated at the time of the IPO, the Company believes there is a significantopportunity to sell additional software products into its customer base and assuch has added two further products to its suite aimed at the finance departmentof US hospitals. In November, Craneware launched Patient Charge Estimator(TM),which enables hospitals to efficiently and accurately provide prospectivepatients with estimates of procedural charges. Yesterday the Company launchedPharmacy ChargeLink(TM) which enables hospitals to improve the buying, billing and reimbursement of pharmacy items. Craneware has started the second half of the year with a strong pipeline ofsales prospects and this together with the new product launches gives managementconfidence for the Company's performance for the full year. Overall, significantprogress has been made in H1 and the Company anticipates further positivenewsflow in H2. Craneware will be announcing Interim results on Tuesday 26thFebruary 2008. Keith Neilson, CEO of Craneware, commented, "We are delighted with the progressmade during the first few months of life as a public company. Cranewarecontinues to grow and we have maintained our leading position as a provider ofrevenue cycle management software to US hospitals. The complexity of legislationgoverning this sector, and the high proportion of hospitals still using manualsolutions to manage their revenue cycles, means we are operating in a vibrantmarketplace with opportunity for growth alongside continuing high levels ofcontract renewals. We look forward to updating shareholders in February." For further information, please contact: Craneware plc KBC Peel Hunt ICIS+44 (0)1506 407 666 +44 (0)20 7418 8900 +44 (0)20 7651 8688Keith Neilson, CEO Oliver Scott Tom MoriartySandy McDougall, CFO Deon Veldtman Caroline Evans-Jones About Craneware Founded in 1999, Craneware has headquarters in Livingston, Scotland, withoffices in Florida, Arizona and Kansas, employing approximately 100 staff. TheCompany's flagship product, Chargemaster Toolkit(R) ("CMT"), assists UShealthcare providers in reducing billing errors, ensuring the timely andaccurate submission of claims and managing compliance risk. More informationabout Craneware plc and its services can be found on-line at the Company'scorporate website, www.craneware.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Apr 20197:00 amRNSBlock listing Interim Review
15th Mar 20192:50 pmRNSDividend Currency Election
5th Mar 20197:00 amRNSHalf-year Report
21st Dec 20187:00 amRNSTrading Update and Notice of Results
15th Nov 20187:00 amRNSHolding(s) in Company
9th Nov 20188:55 amRNSDividend Currency Election
7th Nov 201810:42 amRNSResult of AGM
6th Nov 20187:00 amRNSAGM Statement and Capital Markets Day
16th Oct 20187:00 amRNSBlock listing Interim Review
11th Oct 201810:50 amRNSPosting of Annual Report and Notice of AGM
5th Oct 20184:39 pmRNSTotal Voting Rights
5th Oct 20182:55 pmRNSHolding(s) in Company
18th Sep 20182:06 pmRNSSecond Price Monitoring Extn
18th Sep 20182:00 pmRNSPrice Monitoring Extension
11th Sep 201811:10 amRNSHolding(s) in Company
10th Sep 20187:00 amRNSDirector/PDMR Shareholding
7th Sep 201811:40 amRNSHolding(s) in Company
5th Sep 201812:20 pmRNSGrant of Options & Long Term Incentive Plan Awards
4th Sep 20187:00 amRNSFinal Results
1st Aug 20187:00 amRNSAppointment of Joint Broker
10th Jul 20187:00 amRNSTrading Update and Significant Contract Win
17th Apr 20181:55 pmRNSBlock listing Interim Review
12th Apr 20189:54 amRNSHolding(s) in Company
6th Apr 20183:10 pmRNSDividend Currency Election
27th Mar 20181:52 pmRNSHolding(s) in Company
19th Mar 20187:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
14th Mar 20182:11 pmRNSAdditional Listing - Blocklisting of Securities
8th Mar 20187:00 amRNSDirector/PDMR Shareholding
6th Mar 20187:00 amRNSHalf-year Report
16th Feb 201811:53 amRNSHolding(s) in Company
13th Feb 20187:00 amRNSSignificant Contract Wins
31st Jan 20182:59 pmRNSTotal Voting Rights
26th Jan 20182:49 pmRNSHolding(s) in Company
26th Jan 201812:10 pmRNSTotal Voting Rights and Director/PDMR Shareholding
23rd Jan 201812:05 pmRNSResult of Share Buyback
17th Jan 20185:59 pmRNSGrant of Options & Long Term Incentive Plan Awards
16th Jan 20187:00 amRNSShare Buyback
8th Jan 20187:00 amRNSTrading Update and Significant Contract Win
29th Nov 20177:00 amRNSHolding(s) in Company
10th Nov 20171:43 pmRNSDividend Currency Election
8th Nov 20175:00 pmRNSResult of AGM
8th Nov 20177:00 amRNSAGM Statement
31st Oct 20177:00 amRNSSignificant Contract Win
27th Oct 20172:07 pmRNSHolding(s) in Company
18th Oct 20172:06 pmRNSBlock listing Interim Review
12th Oct 201712:15 pmRNSPosting of Annual Report and Notice of AGM
22nd Sep 201712:06 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSFinal Results
11th Jul 20177:00 amRNSTrading Update
5th Apr 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.